Company Profile
Neo-Pharma Biotech Co., Ltd. was established in 2022 by a team of experts in new drug R&D, dedicated to the innovative design and structural optimization of small molecule drugs. We specialize in revitalizing off-patent therapeutics; by employing precise functional group modifications and advanced chemical synthesis, we redesign and optimize these structures to develop novel small molecule drugs with enhanced clinical value.
Guided by our philosophy of “Innovation, Precision, and Evidence-Based” development, Neo-Pharma Biotech integrates cutting-edge chemistry and pharmacology to bridge the gap between drug discovery and clinical application. Our goal is to build an innovative drug platform that combines scientific rigor with industrial competitiveness, delivering safer and more effective therapeutic options for human health.
Core Technology
Neo-Pharma Biotech is an innovation-driven company specializing in the application of small molecule drugs and biomedical technologies. We provide integrated services ranging from drug design and chemical synthesis to the development of functional raw materials and technical consulting.
Beyond our technical services, we are deeply committed to intellectual property strategy and patent technology transfer, ensuring our innovations maintain strong commercial competitiveness. Backed by expert R&D capabilities and rigorous quality control, we deliver high-quality chemical materials and comprehensive biotechnology solutions to our industry partners.
Latest News
生達方生醫創辦人林伯霖博士於2024年榮獲第三屆環球生技台灣新創CEO獎「新創十大CEO」及「最佳人氣CEO」雙獎項。
